Summary
Biological and Medical Imaging Reagents are chemicals that clinicians and healthcare providers can determine whether a tumor is malignant or benign, and can locate any metastatic cancer in the body, specifically designed to enhance the image produced by the imaging system.
According to APO Research, The global Biologic and Medical Imaging Reagents market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Biologic and Medical Imaging Reagents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Biologic and Medical Imaging Reagents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Biologic and Medical Imaging Reagents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Biologic and Medical Imaging Reagents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Biologic and Medical Imaging Reagents include Cardinal Health, Bracco, Bayer HealthCare, Curium Pharma, Hengrui Medicine, GE Healthcare, Lantheus Medical Imaging, Novartis (AAA) and Thermo Fisher Scientific, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Biologic and Medical Imaging Reagents, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Biologic and Medical Imaging Reagents, also provides the revenue of main regions and countries. Of the upcoming market potential for Biologic and Medical Imaging Reagents, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biologic and Medical Imaging Reagents revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Biologic and Medical Imaging Reagents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Biologic and Medical Imaging Reagents revenue, projected growth trends, production technology, application and end-user industry.
Biologic and Medical Imaging Reagents segment by Company
Cardinal Health
Bracco
Bayer HealthCare
Curium Pharma
Hengrui Medicine
GE Healthcare
Lantheus Medical Imaging
Novartis (AAA)
Thermo Fisher Scientific
Jubilant DraxImage
PerkinElmer
Guerbet
Nihon Medi-Physics
YRPG
Biologic and Medical Imaging Reagents segment by Type
Nuclear Imaging (PET & SPECT) Reagents
Magnetic Resonance Imaging (MRI) Reagents
Fluorescence Imaging Reagents
Ultrasound and X-ray Contrast Reagents
Other
Biologic and Medical Imaging Reagents segment by Application
Hospitals
Clinics
Other
Biologic and Medical Imaging Reagents segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologic and Medical Imaging Reagents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biologic and Medical Imaging Reagents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologic and Medical Imaging Reagents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Biologic and Medical Imaging Reagents in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Biologic and Medical Imaging Reagents company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biologic and Medical Imaging Reagents revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Biologic and Medical Imaging Reagents Market by Type
1.2.1 Global Biologic and Medical Imaging Reagents Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Nuclear Imaging (PET & SPECT) Reagents
1.2.3 Magnetic Resonance Imaging (MRI) Reagents
1.2.4 Fluorescence Imaging Reagents
1.2.5 Ultrasound and X-ray Contrast Reagents
1.2.6 Other
1.3 Biologic and Medical Imaging Reagents Market by Application
1.3.1 Global Biologic and Medical Imaging Reagents Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Biologic and Medical Imaging Reagents Market Dynamics
2.1 Biologic and Medical Imaging Reagents Industry Trends
2.2 Biologic and Medical Imaging Reagents Industry Drivers
2.3 Biologic and Medical Imaging Reagents Industry Opportunities and Challenges
2.4 Biologic and Medical Imaging Reagents Industry Restraints
3 Global Growth Perspective
3.1 Global Biologic and Medical Imaging Reagents Market Perspective (2019-2030)
3.2 Global Biologic and Medical Imaging Reagents Growth Trends by Region
3.2.1 Global Biologic and Medical Imaging Reagents Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Biologic and Medical Imaging Reagents Market Size by Region (2019-2024)
3.2.3 Global Biologic and Medical Imaging Reagents Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Biologic and Medical Imaging Reagents Revenue by Players
4.1.1 Global Biologic and Medical Imaging Reagents Revenue by Players (2019-2024)
4.1.2 Global Biologic and Medical Imaging Reagents Revenue Market Share by Players (2019-2024)
4.1.3 Global Biologic and Medical Imaging Reagents Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Biologic and Medical Imaging Reagents Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Biologic and Medical Imaging Reagents Key Players Headquarters & Area Served
4.4 Global Biologic and Medical Imaging Reagents Players, Product Type & Application
4.5 Global Biologic and Medical Imaging Reagents Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Biologic and Medical Imaging Reagents Market CR5 and HHI
4.6.2 Global Top 5 and 10 Biologic and Medical Imaging Reagents Players Market Share by Revenue in 2023
4.6.3 2023 Biologic and Medical Imaging Reagents Tier 1, Tier 2, and Tier 3
5 Biologic and Medical Imaging Reagents Market Size by Type
5.1 Global Biologic and Medical Imaging Reagents Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Biologic and Medical Imaging Reagents Revenue by Type (2019-2030)
5.3 Global Biologic and Medical Imaging Reagents Revenue Market Share by Type (2019-2030)
6 Biologic and Medical Imaging Reagents Market Size by Application
6.1 Global Biologic and Medical Imaging Reagents Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Biologic and Medical Imaging Reagents Revenue by Application (2019-2030)
6.3 Global Biologic and Medical Imaging Reagents Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Cardinal Health
7.1.1 Cardinal Health Comapny Information
7.1.2 Cardinal Health Business Overview
7.1.3 Cardinal Health Biologic and Medical Imaging Reagents Revenue and Gross Margin (2019-2024)
7.1.4 Cardinal Health Biologic and Medical Imaging Reagents Product Portfolio
7.1.5 Cardinal Health Recent Developments
7.2 Bracco
7.2.1 Bracco Comapny Information
7.2.2 Bracco Business Overview
7.2.3 Bracco Biologic and Medical Imaging Reagents Revenue and Gross Margin (2019-2024)
7.2.4 Bracco Biologic and Medical Imaging Reagents Product Portfolio
7.2.5 Bracco Recent Developments
7.3 Bayer HealthCare
7.3.1 Bayer HealthCare Comapny Information
7.3.2 Bayer HealthCare Business Overview
7.3.3 Bayer HealthCare Biologic and Medical Imaging Reagents Revenue and Gross Margin (2019-2024)
7.3.4 Bayer HealthCare Biologic and Medical Imaging Reagents Product Portfolio
7.3.5 Bayer HealthCare Recent Developments
7.4 Curium Pharma
7.4.1 Curium Pharma Comapny Information
7.4.2 Curium Pharma Business Overview
7.4.3 Curium Pharma Biologic and Medical Imaging Reagents Revenue and Gross Margin (2019-2024)
7.4.4 Curium Pharma Biologic and Medical Imaging Reagents Product Portfolio
7.4.5 Curium Pharma Recent Developments
7.5 Hengrui Medicine
7.5.1 Hengrui Medicine Comapny Information
7.5.2 Hengrui Medicine Business Overview
7.5.3 Hengrui Medicine Biologic and Medical Imaging Reagents Revenue and Gross Margin (2019-2024)
7.5.4 Hengrui Medicine Biologic and Medical Imaging Reagents Product Portfolio
7.5.5 Hengrui Medicine Recent Developments
7.6 GE Healthcare
7.6.1 GE Healthcare Comapny Information
7.6.2 GE Healthcare Business Overview
7.6.3 GE Healthcare Biologic and Medical Imaging Reagents Revenue and Gross Margin (2019-2024)
7.6.4 GE Healthcare Biologic and Medical Imaging Reagents Product Portfolio
7.6.5 GE Healthcare Recent Developments
7.7 Lantheus Medical Imaging
7.7.1 Lantheus Medical Imaging Comapny Information
7.7.2 Lantheus Medical Imaging Business Overview
7.7.3 Lantheus Medical Imaging Biologic and Medical Imaging Reagents Revenue and Gross Margin (2019-2024)
7.7.4 Lantheus Medical Imaging Biologic and Medical Imaging Reagents Product Portfolio
7.7.5 Lantheus Medical Imaging Recent Developments
7.8 Novartis (AAA)
7.8.1 Novartis (AAA) Comapny Information
7.8.2 Novartis (AAA) Business Overview
7.8.3 Novartis (AAA) Biologic and Medical Imaging Reagents Revenue and Gross Margin (2019-2024)
7.8.4 Novartis (AAA) Biologic and Medical Imaging Reagents Product Portfolio
7.8.5 Novartis (AAA) Recent Developments
7.9 Thermo Fisher Scientific
7.9.1 Thermo Fisher Scientific Comapny Information
7.9.2 Thermo Fisher Scientific Business Overview
7.9.3 Thermo Fisher Scientific Biologic and Medical Imaging Reagents Revenue and Gross Margin (2019-2024)
7.9.4 Thermo Fisher Scientific Biologic and Medical Imaging Reagents Product Portfolio
7.9.5 Thermo Fisher Scientific Recent Developments
7.10 Jubilant DraxImage
7.10.1 Jubilant DraxImage Comapny Information
7.10.2 Jubilant DraxImage Business Overview
7.10.3 Jubilant DraxImage Biologic and Medical Imaging Reagents Revenue and Gross Margin (2019-2024)
7.10.4 Jubilant DraxImage Biologic and Medical Imaging Reagents Product Portfolio
7.10.5 Jubilant DraxImage Recent Developments
7.11 PerkinElmer
7.11.1 PerkinElmer Comapny Information
7.11.2 PerkinElmer Business Overview
7.11.3 PerkinElmer Biologic and Medical Imaging Reagents Revenue and Gross Margin (2019-2024)
7.11.4 PerkinElmer Biologic and Medical Imaging Reagents Product Portfolio
7.11.5 PerkinElmer Recent Developments
7.12 Guerbet
7.12.1 Guerbet Comapny Information
7.12.2 Guerbet Business Overview
7.12.3 Guerbet Biologic and Medical Imaging Reagents Revenue and Gross Margin (2019-2024)
7.12.4 Guerbet Biologic and Medical Imaging Reagents Product Portfolio
7.12.5 Guerbet Recent Developments
7.13 Nihon Medi-Physics
7.13.1 Nihon Medi-Physics Comapny Information
7.13.2 Nihon Medi-Physics Business Overview
7.13.3 Nihon Medi-Physics Biologic and Medical Imaging Reagents Revenue and Gross Margin (2019-2024)
7.13.4 Nihon Medi-Physics Biologic and Medical Imaging Reagents Product Portfolio
7.13.5 Nihon Medi-Physics Recent Developments
7.14 YRPG
7.14.1 YRPG Comapny Information
7.14.2 YRPG Business Overview
7.14.3 YRPG Biologic and Medical Imaging Reagents Revenue and Gross Margin (2019-2024)
7.14.4 YRPG Biologic and Medical Imaging Reagents Product Portfolio
7.14.5 YRPG Recent Developments
8 North America
8.1 North America Biologic and Medical Imaging Reagents Revenue (2019-2030)
8.2 North America Biologic and Medical Imaging Reagents Revenue by Type (2019-2030)
8.2.1 North America Biologic and Medical Imaging Reagents Revenue by Type (2019-2024)
8.2.2 North America Biologic and Medical Imaging Reagents Revenue by Type (2025-2030)
8.3 North America Biologic and Medical Imaging Reagents Revenue Share by Type (2019-2030)
8.4 North America Biologic and Medical Imaging Reagents Revenue by Application (2019-2030)
8.4.1 North America Biologic and Medical Imaging Reagents Revenue by Application (2019-2024)
8.4.2 North America Biologic and Medical Imaging Reagents Revenue by Application (2025-2030)
8.5 North America Biologic and Medical Imaging Reagents Revenue Share by Application (2019-2030)
8.6 North America Biologic and Medical Imaging Reagents Revenue by Country
8.6.1 North America Biologic and Medical Imaging Reagents Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Biologic and Medical Imaging Reagents Revenue by Country (2019-2024)
8.6.3 North America Biologic and Medical Imaging Reagents Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Biologic and Medical Imaging Reagents Revenue (2019-2030)
9.2 Europe Biologic and Medical Imaging Reagents Revenue by Type (2019-2030)
9.2.1 Europe Biologic and Medical Imaging Reagents Revenue by Type (2019-2024)
9.2.2 Europe Biologic and Medical Imaging Reagents Revenue by Type (2025-2030)
9.3 Europe Biologic and Medical Imaging Reagents Revenue Share by Type (2019-2030)
9.4 Europe Biologic and Medical Imaging Reagents Revenue by Application (2019-2030)
9.4.1 Europe Biologic and Medical Imaging Reagents Revenue by Application (2019-2024)
9.4.2 Europe Biologic and Medical Imaging Reagents Revenue by Application (2025-2030)
9.5 Europe Biologic and Medical Imaging Reagents Revenue Share by Application (2019-2030)
9.6 Europe Biologic and Medical Imaging Reagents Revenue by Country
9.6.1 Europe Biologic and Medical Imaging Reagents Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Biologic and Medical Imaging Reagents Revenue by Country (2019-2024)
9.6.3 Europe Biologic and Medical Imaging Reagents Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Biologic and Medical Imaging Reagents Revenue (2019-2030)
10.2 China Biologic and Medical Imaging Reagents Revenue by Type (2019-2030)
10.2.1 China Biologic and Medical Imaging Reagents Revenue by Type (2019-2024)
10.2.2 China Biologic and Medical Imaging Reagents Revenue by Type (2025-2030)
10.3 China Biologic and Medical Imaging Reagents Revenue Share by Type (2019-2030)
10.4 China Biologic and Medical Imaging Reagents Revenue by Application (2019-2030)
10.4.1 China Biologic and Medical Imaging Reagents Revenue by Application (2019-2024)
10.4.2 China Biologic and Medical Imaging Reagents Revenue by Application (2025-2030)
10.5 China Biologic and Medical Imaging Reagents Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Biologic and Medical Imaging Reagents Revenue (2019-2030)
11.2 Asia Biologic and Medical Imaging Reagents Revenue by Type (2019-2030)
11.2.1 Asia Biologic and Medical Imaging Reagents Revenue by Type (2019-2024)
11.2.2 Asia Biologic and Medical Imaging Reagents Revenue by Type (2025-2030)
11.3 Asia Biologic and Medical Imaging Reagents Revenue Share by Type (2019-2030)
11.4 Asia Biologic and Medical Imaging Reagents Revenue by Application (2019-2030)
11.4.1 Asia Biologic and Medical Imaging Reagents Revenue by Application (2019-2024)
11.4.2 Asia Biologic and Medical Imaging Reagents Revenue by Application (2025-2030)
11.5 Asia Biologic and Medical Imaging Reagents Revenue Share by Application (2019-2030)
11.6 Asia Biologic and Medical Imaging Reagents Revenue by Country
11.6.1 Asia Biologic and Medical Imaging Reagents Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Biologic and Medical Imaging Reagents Revenue by Country (2019-2024)
11.6.3 Asia Biologic and Medical Imaging Reagents Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Biologic and Medical Imaging Reagents Revenue (2019-2030)
12.2 MEALA Biologic and Medical Imaging Reagents Revenue by Type (2019-2030)
12.2.1 MEALA Biologic and Medical Imaging Reagents Revenue by Type (2019-2024)
12.2.2 MEALA Biologic and Medical Imaging Reagents Revenue by Type (2025-2030)
12.3 MEALA Biologic and Medical Imaging Reagents Revenue Share by Type (2019-2030)
12.4 MEALA Biologic and Medical Imaging Reagents Revenue by Application (2019-2030)
12.4.1 MEALA Biologic and Medical Imaging Reagents Revenue by Application (2019-2024)
12.4.2 MEALA Biologic and Medical Imaging Reagents Revenue by Application (2025-2030)
12.5 MEALA Biologic and Medical Imaging Reagents Revenue Share by Application (2019-2030)
12.6 MEALA Biologic and Medical Imaging Reagents Revenue by Country
12.6.1 MEALA Biologic and Medical Imaging Reagents Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Biologic and Medical Imaging Reagents Revenue by Country (2019-2024)
12.6.3 MEALA Biologic and Medical Imaging Reagents Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Biologic and Medical Imaging Reagents Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Nuclear Imaging (PET & SPECT) Reagents Major Manufacturers
Table 2. Magnetic Resonance Imaging (MRI) Reagents Major Manufacturers
Table 3. Fluorescence Imaging Reagents Major Manufacturers
Table 4. Ultrasound and X-ray Contrast Reagents Major Manufacturers
Table 5. Other Major Manufacturers
Table 6. Global Biologic and Medical Imaging Reagents Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 7. Hospitals Major Manufacturers
Table 8. Clinics Major Manufacturers
Table 9. Other Major Manufacturers
Table 10. Biologic and Medical Imaging Reagents Industry Trends
Table 11. Biologic and Medical Imaging Reagents Industry Drivers
Table 12. Biologic and Medical Imaging Reagents Industry Opportunities and Challenges
Table 13. Biologic and Medical Imaging Reagents Industry Restraints
Table 14. Global Biologic and Medical Imaging Reagents Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 15. Global Biologic and Medical Imaging Reagents Market Size by Region (2019-2024) & (US$ Million)
Table 16. Global Biologic and Medical Imaging Reagents Market Share by Region (2019-2024)
Table 17. Global Biologic and Medical Imaging Reagents Market Size by Region (2025-2030) & (US$ Million)
Table 18. Global Biologic and Medical Imaging Reagents Market Share by Region (2025-2030)
Table 19. Global Biologic and Medical Imaging Reagents Revenue by Players (US$ Million) & (2019-2024)
Table 20. Global Biologic and Medical Imaging Reagents Revenue Market Share by Players (2019-2024)
Table 21. Global Biologic and Medical Imaging Reagents Key Players Ranking, 2022 VS 2023 VS 2024
Table 22. Global Biologic and Medical Imaging Reagents Key Players Headquarters & Area Served
Table 23. Global Biologic and Medical Imaging Reagents Players, Product Type & Application
Table 24. Global Biologic and Medical Imaging Reagents Players Commercialization Time
Table 25. Global Players Market Concentration Ratio (CR5 and HHI)
Table 26. Global Biologic and Medical Imaging Reagents by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 27. Global Biologic and Medical Imaging Reagents Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 28. Global Biologic and Medical Imaging Reagents Revenue by Type (2019-2024) & (US$ Million)
Table 29. Global Biologic and Medical Imaging Reagents Revenue by Type (2025-2030) & (US$ Million)
Table 30. Global Biologic and Medical Imaging Reagents Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 31. Global Biologic and Medical Imaging Reagents Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 32. Global Biologic and Medical Imaging Reagents Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 33. Global Biologic and Medical Imaging Reagents Revenue by Application (2019-2024) & (US$ Million)
Table 34. Global Biologic and Medical Imaging Reagents Revenue by Application (2025-2030) & (US$ Million)
Table 35. Global Biologic and Medical Imaging Reagents Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 36. Global Biologic and Medical Imaging Reagents Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 37. Cardinal Health Company Information
Table 38. Cardinal Health Business Overview
Table 39. Cardinal Health Biologic and Medical Imaging Reagents Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 40. Cardinal Health Biologic and Medical Imaging Reagents Product Portfolio
Table 41. Cardinal Health Recent Development
Table 42. Bracco Company Information
Table 43. Bracco Business Overview
Table 44. Bracco Biologic and Medical Imaging Reagents Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 45. Bracco Biologic and Medical Imaging Reagents Product Portfolio
Table 46. Bracco Recent Development
Table 47. Bayer HealthCare Company Information
Table 48. Bayer HealthCare Business Overview
Table 49. Bayer HealthCare Biologic and Medical Imaging Reagents Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 50. Bayer HealthCare Biologic and Medical Imaging Reagents Product Portfolio
Table 51. Bayer HealthCare Recent Development
Table 52. Curium Pharma Company Information
Table 53. Curium Pharma Business Overview
Table 54. Curium Pharma Biologic and Medical Imaging Reagents Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 55. Curium Pharma Biologic and Medical Imaging Reagents Product Portfolio
Table 56. Curium Pharma Recent Development
Table 57. Hengrui Medicine Company Information
Table 58. Hengrui Medicine Business Overview
Table 59. Hengrui Medicine Biologic and Medical Imaging Reagents Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 60. Hengrui Medicine Biologic and Medical Imaging Reagents Product Portfolio
Table 61. Hengrui Medicine Recent Development
Table 62. GE Healthcare Company Information
Table 63. GE Healthcare Business Overview
Table 64. GE Healthcare Biologic and Medical Imaging Reagents Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 65. GE Healthcare Biologic and Medical Imaging Reagents Product Portfolio
Table 66. GE Healthcare Recent Development
Table 67. Lantheus Medical Imaging Company Information
Table 68. Lantheus Medical Imaging Business Overview
Table 69. Lantheus Medical Imaging Biologic and Medical Imaging Reagents Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 70. Lantheus Medical Imaging Biologic and Medical Imaging Reagents Product Portfolio
Table 71. Lantheus Medical Imaging Recent Development
Table 72. Novartis (AAA) Company Information
Table 73. Novartis (AAA) Business Overview
Table 74. Novartis (AAA) Biologic and Medical Imaging Reagents Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 75. Novartis (AAA) Biologic and Medical Imaging Reagents Product Portfolio
Table 76. Novartis (AAA) Recent Development
Table 77. Thermo Fisher Scientific Company Information
Table 78. Thermo Fisher Scientific Business Overview
Table 79. Thermo Fisher Scientific Biologic and Medical Imaging Reagents Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 80. Thermo Fisher Scientific Biologic and Medical Imaging Reagents Product Portfolio
Table 81. Thermo Fisher Scientific Recent Development
Table 82. Jubilant DraxImage Company Information
Table 83. Jubilant DraxImage Business Overview
Table 84. Jubilant DraxImage Biologic and Medical Imaging Reagents Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 85. Jubilant DraxImage Biologic and Medical Imaging Reagents Product Portfolio
Table 86. Jubilant DraxImage Recent Development
Table 87. PerkinElmer Company Information
Table 88. PerkinElmer Business Overview
Table 89. PerkinElmer Biologic and Medical Imaging Reagents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 90. PerkinElmer Biologic and Medical Imaging Reagents Product Portfolio
Table 91. PerkinElmer Recent Development
Table 92. Guerbet Company Information
Table 93. Guerbet Business Overview
Table 94. Guerbet Biologic and Medical Imaging Reagents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 95. Guerbet Biologic and Medical Imaging Reagents Product Portfolio
Table 96. Guerbet Recent Development
Table 97. Nihon Medi-Physics Company Information
Table 98. Nihon Medi-Physics Business Overview
Table 99. Nihon Medi-Physics Biologic and Medical Imaging Reagents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 100. Nihon Medi-Physics Biologic and Medical Imaging Reagents Product Portfolio
Table 101. Nihon Medi-Physics Recent Development
Table 102. YRPG Company Information
Table 103. YRPG Business Overview
Table 104. YRPG Biologic and Medical Imaging Reagents Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 105. YRPG Biologic and Medical Imaging Reagents Product Portfolio
Table 106. YRPG Recent Development
Table 107. North America Biologic and Medical Imaging Reagents Revenue by Type (2019-2024) & (US$ Million)
Table 108. North America Biologic and Medical Imaging Reagents Revenue by Application (2019-2024) & (US$ Million)
Table 109. North America Biologic and Medical Imaging Reagents Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 110. North America Biologic and Medical Imaging Reagents Revenue by Country (2019-2024) & (US$ Million)
Table 111. North America Biologic and Medical Imaging Reagents Revenue by Country (2025-2030) & (US$ Million)
Table 112. Europe Biologic and Medical Imaging Reagents Revenue by Type (2019-2024) & (US$ Million)
Table 113. Europe Biologic and Medical Imaging Reagents Revenue by Application (2019-2024) & (US$ Million)
Table 114. Europe Biologic and Medical Imaging Reagents Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 115. Europe Biologic and Medical Imaging Reagents Revenue by Country (2019-2024) & (US$ Million)
Table 116. Europe Biologic and Medical Imaging Reagents Revenue by Country (2025-2030) & (US$ Million)
Table 117. China Biologic and Medical Imaging Reagents Revenue by Type (2019-2024) & (US$ Million)
Table 118. China Biologic and Medical Imaging Reagents Revenue by Application (2019-2024) & (US$ Million)
Table 119. Asia Biologic and Medical Imaging Reagents Revenue by Type (2019-2024) & (US$ Million)
Table 120. Asia Biologic and Medical Imaging Reagents Revenue by Application (2019-2024) & (US$ Million)
Table 121. Asia Biologic and Medical Imaging Reagents Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 122. Asia Biologic and Medical Imaging Reagents Revenue by Country (2019-2024) & (US$ Million)
Table 123. Asia Biologic and Medical Imaging Reagents Revenue by Country (2025-2030) & (US$ Million)
Table 124. MEALA Biologic and Medical Imaging Reagents Revenue by Type (2019-2024) & (US$ Million)
Table 125. MEALA Biologic and Medical Imaging Reagents Revenue by Application (2019-2024) & (US$ Million)
Table 126. MEALA Biologic and Medical Imaging Reagents Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 127. MEALA Biologic and Medical Imaging Reagents Revenue by Country (2019-2024) & (US$ Million)
Table 128. MEALA Biologic and Medical Imaging Reagents Revenue by Country (2025-2030) & (US$ Million)
Table 129. Research Programs/Design for This Report
Table 130. Authors List of This Report
Table 131. Secondary Sources
Table 132. Primary Sources
List of Figures
Figure 1. Biologic and Medical Imaging Reagents Product Picture
Figure 2. Global Biologic and Medical Imaging Reagents Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Biologic and Medical Imaging Reagents Market Size Share 2019 VS 2023 VS 2030
Figure 4. Nuclear Imaging (PET & SPECT) Reagents Picture
Figure 5. Magnetic Resonance Imaging (MRI) Reagents Picture
Figure 6. Fluorescence Imaging Reagents Picture
Figure 7. Ultrasound and X-ray Contrast Reagents Picture
Figure 8. Other Picture
Figure 9. Global Biologic and Medical Imaging Reagents Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 10. Global Biologic and Medical Imaging Reagents Market Size Share 2019 VS 2023 VS 2030
Figure 11. Hospitals Picture
Figure 12. Clinics Picture
Figure 13. Other Picture
Figure 14. Global Biologic and Medical Imaging Reagents Market Size (US$ Million) & (2019-2030)
Figure 15. Global Biologic and Medical Imaging Reagents Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Biologic and Medical Imaging Reagents Market Share by Region: 2019 VS 2023 VS 2030
Figure 17. Global Biologic and Medical Imaging Reagents Players Revenue Share Top 10 and Top 5 in 2023
Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 19. Global Biologic and Medical Imaging Reagents Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Biologic and Medical Imaging Reagents Revenue Market Share 2019 VS 2023 VS 2030
Figure 21. Global Biologic and Medical Imaging Reagents Revenue Market Share by Type (2019-2030)
Figure 22. Global Biologic and Medical Imaging Reagents Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Biologic and Medical Imaging Reagents Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 24. Global Biologic and Medical Imaging Reagents Revenue Market Share by Application (2019-2030)
Figure 25. North America Biologic and Medical Imaging Reagents Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 26. North America Biologic and Medical Imaging Reagents Revenue by Type (2025-2030) & (US$ Million)
Figure 27. North America Biologic and Medical Imaging Reagents Revenue Share by Type (2019-2030)
Figure 28. North America Biologic and Medical Imaging Reagents Revenue by Application (2025-2030) & (US$ Million)
Figure 29. North America Biologic and Medical Imaging Reagents Revenue Share by Application (2019-2030)
Figure 30. North America Biologic and Medical Imaging Reagents Revenue Share by Country (2019-2030)
Figure 31. United States Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 32. Canada Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 33. Europe Biologic and Medical Imaging Reagents Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 34. Europe Biologic and Medical Imaging Reagents Revenue by Type (2025-2030) & (US$ Million)
Figure 35. Europe Biologic and Medical Imaging Reagents Revenue Share by Type (2019-2030)
Figure 36. Europe Biologic and Medical Imaging Reagents Revenue by Application (2025-2030) & (US$ Million)
Figure 37. Europe Biologic and Medical Imaging Reagents Revenue Share by Application (2019-2030)
Figure 38. Europe Biologic and Medical Imaging Reagents Revenue Share by Country (2019-2030)
Figure 39. Germany Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. France Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. U.K. Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. Italy Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 43. Russia Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 44. Nordic Countries Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 45. China Biologic and Medical Imaging Reagents Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 46. China Biologic and Medical Imaging Reagents Revenue by Type (2025-2030) & (US$ Million)
Figure 47. China Biologic and Medical Imaging Reagents Revenue Share by Type (2019-2030)
Figure 48. China Biologic and Medical Imaging Reagents Revenue by Application (2025-2030) & (US$ Million)
Figure 49. China Biologic and Medical Imaging Reagents Revenue Share by Application (2019-2030)
Figure 50. Asia Biologic and Medical Imaging Reagents Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 51. Asia Biologic and Medical Imaging Reagents Revenue by Type (2025-2030) & (US$ Million)
Figure 52. Asia Biologic and Medical Imaging Reagents Revenue Share by Type (2019-2030)
Figure 53. Asia Biologic and Medical Imaging Reagents Revenue by Application (2025-2030) & (US$ Million)
Figure 54. Asia Biologic and Medical Imaging Reagents Revenue Share by Application (2019-2030)
Figure 55. Asia Biologic and Medical Imaging Reagents Revenue Share by Country (2019-2030)
Figure 56. Japan Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. South Korea Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. India Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. Australia Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 60. China Taiwan Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 61. Southeast Asia Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 62. MEALA Biologic and Medical Imaging Reagents Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 63. MEALA Biologic and Medical Imaging Reagents Revenue by Type (2025-2030) & (US$ Million)
Figure 64. MEALA Biologic and Medical Imaging Reagents Revenue Share by Type (2019-2030)
Figure 65. MEALA Biologic and Medical Imaging Reagents Revenue by Application (2025-2030) & (US$ Million)
Figure 66. MEALA Biologic and Medical Imaging Reagents Revenue Share by Application (2019-2030)
Figure 67. MEALA Biologic and Medical Imaging Reagents Revenue Share by Country (2019-2030)
Figure 68. Mexico Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. South Korea Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Brazil Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Israel Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Argentina Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Colombia Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Turkey Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 75. Saudi Arabia Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 76. UAE Biologic and Medical Imaging Reagents Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 77. Years Considered
Figure 78. Research Process
Figure 79. Key Executives Interviewed
